Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcutis Biotherapeutics (ARQT) Other Gross PP&E Adjustments (2020 - 2025)

Arcutis Biotherapeutics has reported Other Gross PP&E Adjustments over the past 6 years, most recently at -$7.9 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at -$7.9 million for Q4 2025, up 43.87% from a year ago — trailing twelve months through Dec 2025 was -$7.9 million (up 43.87% YoY), and the annual figure for FY2025 was -$7.9 million, up 43.87%.
  • Other Gross PP&E Adjustments for Q4 2025 was -$7.9 million at Arcutis Biotherapeutics, down from -$4.6 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for ARQT hit a ceiling of $818000.0 in Q3 2023 and a floor of -$14.1 million in Q4 2024.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$1.8 million (2025), compared with a mean of -$2.9 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 1378.12% in 2023 and later crashed 1215.27% in 2024.
  • Arcutis Biotherapeutics' Other Gross PP&E Adjustments stood at -$4.4 million in 2021, then crashed by 71.6% to -$7.5 million in 2022, then decreased by 13.51% to -$8.5 million in 2023, then crashed by 65.64% to -$14.1 million in 2024, then surged by 43.87% to -$7.9 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$7.9 million (Q4 2025), -$4.6 million (Q3 2025), and -$1.7 million (Q2 2025) per Business Quant data.